Clinical outcome of diabetic peritoneal dialysis patients and evaluation of factors affecting mortality: A single centre's experience from turkey

Journal of Renal Care

Volumn 37, Issue 2, 2011, Pages 94-100

  Koc, Yener ^a   Unsal, Abdulkadir ^a   Ahbap, Elbis ^a   Sakaci, Tamer ^a   Yilmaz, Murvet ^a  

^a Sisli Etfal Research and Educational Hospital   (Turkey)

Author keywords

Cardiovascular; Diabetic; Peritoneal dialysis; Treatment outcomes

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATIENT; PERITONEAL DIALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; TURKEY (REPUBLIC);

AGE DISTRIBUTION; CAUSE OF DEATH; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT DROPOUTS; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 79955756978     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2011.00218.x     Document Type: Article

References (38)

1. Akmal M. (2001). Hemodialysis in diabetic patients. American Journal of Kidney Diseases 38(Suppl 1), S195-S199.
2. Avram M.M., Mittman N., Myint M.M. et al. (2001). Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. American Journal of Kidney Diseases 38, 1351-1357.
3. Block G.A., Klassen P.S., Lazarus J.M. et al. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of the American Society of Nephrology 15, 2208-2218.
4. Carmen Sanchez M., Auxiliadora Bajo M., Selgas R. et al. (2000). Parathormone secretion in peritoneal dialysis patients with adynamic bone disease. American Journal of Kidney Diseases 36(5), 953-961.
5. Collins A.J., Hao W., Xia H. et al. (1999). Mortality risks of peritoneal dialysis and hemodialysis. American Journal of Kidney Diseases 34, 1065-1074.
6. Fang W., Yang X., Kothari J. et al. (2008). Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. Clinical Nephrology 69, 193-200.
7. Feest T.G., Dunn E.J. & Burton C.J. (1999). Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure. Quarterly Journal of Medicine 92(5), 275-282.
8. Guh J.Y., Chen H.C., Chuang H.Y. et al. (2002). Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. American Journal of Kidney Diseases 39, 1245-1254.
9. Hedback G. & Oden A. (1998). Increased risk of death from primary hyperparathyroidism-an update. European Journal of Clinical Investigation 28, 271-276.
10. Held P.J., Port F.K., Turenne M.N., et al. (1994). Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney International 45, 1163-1169.
11. Herzog C.A., Ma J.Z. & Collins A.J. (1998). Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. The New England Journal of Medicine 339, 799-805.
12. Ibrahim H.A. & Vora J.P. (1999). Diabetic nephropathy. Baillieres Best Practice & Research Clinical Endocrinology & Metabolism 13(2), 239-264.
13. Iseki K., Kinjo K., Kimura Y. et al. (1993). Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney International 44, 1086-1090.
14. Krediet R.T. (2005). European best practice guidelines for peritoneal dialysis: adequacy of peritoneal dialysis. Nephrology Dialysis Transplantation 20(Suppl 9), 24-27.
15. Lo W-K., Ho Y-W., Li C-S. et al. (2003). Effects of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney International 64, 649-656.
16. Lowrie E.G., Huang W.H. & Lew N.L. (1995). Death risk predictors among peritoneal dialysis and hemodialysis patients: A preliminary comparison. American Journal of Kidney Diseases 26, 220-228.
17. National Hemodialysis, Transplantation and Nephrology Registry Report of Turkey (2007). (last accessed June 2010).
18. Nilsson I.L., Yin L., Lundgren E. et al. (2002). Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes. Journal of Bone and Mineral Research 17(Suppl 2), 68-74.
19. Noordzij M., Korevaar J.C., Boeschoten E.W. et al. (2005). The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. American Journal of Kidney Diseases 46, 925-932.
20. Noordzij M., Korevaar J.C., Bos W.J. et al. (2006). Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrology Dialysis Transplantation 21, 2513-2520.
21. Ohashi H., Oda H., Ohno M., et al. (1999). Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of left ventricular hypertrophy and diabetic nephropathy. Advances in Peritoneal Dialysis 15, 87-90.
22. Paniagua R., Amato D., Vonesh E. et al. (2002). Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADAMEX, a prospective, randomized, controlled trial. Journal of the American Society of Nephrology 13, 1307-1320.
23. Parfrey P.S., Foley R.N., Hernet J.D. et al. (1996). Outcome and risk factors of ischaemic heart disease in chronic uremia. Kidney International 49, 1428-1434.
24. Passadakis P. & Oreopoulos D.G. (1998). Continuous ambulatory peritoneal dialysis in 224 diabetics with end stage renal disease: Evidence of improved survival over the past 10 years. In Diabetic Renal-Retinal Syndrome-21st Century Management Now (eds Friedman EA, L'Esperance FA), pp. 89-115. Boston Kluwer Academic Publishers.
25. Passadakis P., Thodis E., Vargemezis V. et al. (2001). Long-term survival with peritoneal dialysis in ESRD due to diabetes. Clinical Nephrology 56, 257-270.
26. Piraino B., Bailie G.R., Bernardini J. et al. (2005). ISPD guidelines; Peritoneal dialysis-related infections recommendations: 2005 update. Peritoneal Dialysis International 25, 107-131.
27. Sancho A., Perez Ruixo J.J., Gorriz J.L. et al. (2001). Risk factors associated with survival in patients in a peritoneal dialysis program. Nefrologia 21(2), 160-166.
28. Satoru K. (2007). Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages. Peritoneal Dialysis International 27(S2), 190-195.
29. Tentori F., Blayney M.J., Albert J.M. et al. (2008). Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 52, 519-530.
30. Termorshuizen F., Korevaar J., Dekker F. et al. (2003). Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2. Journal of the American Society of Nephrology 14, 2851-2860.
31. United States Renal Data System (2009). Excerpts from the USRDS 2008 annual data report: Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases (Suppl 1), S37-S46.
32. United States Renal Data System 2005 Annual Report (2006). ESRD clinical performance measures project. American Journal of Kidney Diseases 48(Suppl 1), S10-S16.
33. United States Renal Data System (2007). Excerpts from the USRDS 2006 annual data report: Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 49(Suppl 1), S67-S84.
34. Van Dijk P.C., Jager, K.J., Stengel, B. et al. (2005). Renal replacement therapy for diabetic end-stage renal disease: Data from 10 registries in Europe (1991-2000). Kidney International 67(4), 1489-1499.
35. Viglino G., Cancarini C., Catizone R. et al. (1994). Ten years experience of CAPD in diabetics: comparison of results with nondiabetics. Nephrology Dialysis Transplantation 9, 1443-1448.
36. Vonesh E. & Moran J. (1999). Mortality in End-Stage Renal Disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. Journal of the American Society of Nephrology 10, 354-365.
37. Young E.W., Albert J.M., Satayathum S. et al. (2005). Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney International 67, 1179-1187.
38. Zimmerman S.W., Oxton L.L., Bidwell D. et al. (1996). Long-term outcome of diabetic patients receiving peritoneal dialysis. Peritoneal Dialysis International 16, 63-68.